Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, the first modular mRNA workshop in China, has been delivered
Media
Sep 7, 2021
Walvax
On September 1, 2021, Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, was officially delivered. It is an advanced process combining modular buildings with conventionally built facilities, which allows for tighter construction and can accelerate the industrialization schedule of SARS-CoV-2 mRNA Vaccine. Construction of modular buildings can occur simultaneously with the site and foundation work, allowing projects to be completed in a shorter period.
Related Links
Sep 18, 2024
Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI
Learn More
Jun 3, 2020
HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries
Learn More
Nov 2, 2023
Walvax presents safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® at Leading Scientific Conferences
Learn More